NYSE · Analyst Forecast

Novartis AG (NVS) Stock Forecast & Price Target

$159.19 NYSE: NVS Market Cap $300.65B

Price as of Nov 17, 2026 (intraday, delayed) · Analyst estimates retrieved Nov 11, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Novartis AG (NVS), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Novartis AG, analysts forecast revenue rising from $55.47B in 2025 to $71.06B in 2030; the average estimate for 2030 earnings per share is $12.92; with published estimates ranging from $12.52 to $13.36; 13 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$159.19
Consensus targetThe average of the price targets analysts have published.$149.50
Median targetThe middle target, less affected by a single outlier.$149.50
Highest targetThe most optimistic published target.$163.00
Lowest targetThe most pessimistic published target.$136.00
Difference from priceHow far the consensus target sits from today’s price.-6.1%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$53.33B$55.47B$56.26B13
2026$56.18B$57.27B$58.37B13
2027$60.35B$61.06B$61.83B13
2028$63.34B$64.90B$66.59B7
2029$66.54B$68.18B$69.95B11
2030$69.36B$71.06B$72.92B6

Earnings per share forecast

YearLowAverageHighAnalysts
2025$8.59$8.93$9.0613
2026$8.70$8.90$9.0313
2027$9.69$9.88$10.2013
2028$10.48$10.82$11.187
2029$11.66$12.04$12.4411
2030$12.52$12.92$13.366

Novartis AG (NVS) forecast — frequently asked questions

What is the analyst price target for Novartis AG?

Analysts covering Novartis AG (NVS) have a consensus price target of $149.50, 6.1% below the current price of $159.19. Published targets range from $136.00 to $163.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Novartis AG's earnings?

The average analyst estimate for Novartis AG (NVS) earnings per share in 2030 is 12.92, with individual estimates between 12.52 and 13.36.

How much revenue is Novartis AG expected to make?

Analysts forecast Novartis AG (NVS) revenue of $71.06B in 2030, based on 6 published estimates.

How many analysts cover NVS?

13 analysts contribute estimates for Novartis AG (NVS). Thin coverage makes an average less reliable.

Analyst forecasts for other Drug Manufacturers - General stocks

LLY forecastJNJ forecastABBV forecastMRK forecastAZN forecastAMGN forecastGILD forecastNVO forecastPFE forecastBMY forecastAll Drug Manufacturers - General stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.